BASELINE CHARACTERISTICS OF PATIENTS IN THE SATURN STUDY, A COMPARISON OF ROSUVASTATIN VERSUS ATORVASTATIN ON CORONARY ATHEROSCLEROTIC DISEASE BURDEN

被引：0
|
作者：
Barter, P. J. [1 ]
Chapman, J. [2 ]
Ballantyne, C. [3 ]
Erbel, R. [4 ]
Libby, P. [5 ]
Nicholls, S. [6 ]
Raichlen, J. [7 ]
Cain, V. [7 ]
Nissen, S. [6 ]
机构：
[1] Heart Res Inst, Sydney, NSW, Australia
[2] Hop Pitie, F-75651 Paris, France
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] W German Heart Ctr, Essen, Germany
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[7] AstraZeneca, Wilmington, DE USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70064-7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
L4
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [31] Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients
    Tian, Jianwei
    Hou, Xiaoyan
    Hu, Liping
    Chen, Ting
    Wu, Kefei
    Cai, Chudan
    Bai, Xiaoyan
    RENAL FAILURE, 2017, 39 (01) : 153 - 158
  • [32] Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
    Małgorzata Olszewska-Banaszczyk
    Paulina Jackowska
    Paulina Gorzelak-Pabiś
    Edyta Pytel
    Maria Koter-Michalak
    Marlena Broncel
    Pharmacological Reports, 2018, 70 : 258 - 262
  • [33] Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
    Olszewska-Banaszczyk, Malgorzata
    Jackowska, Paulina
    Gorzelak-Pabis, Paulina
    Pytel, Edyta
    Koter-Michalak, Maria
    Broncel, Marlena
    PHARMACOLOGICAL REPORTS, 2018, 70 (02) : 258 - 262
  • [34] A Comparison on Effects of High Dose Rosuvastatin versus High Dose Atorvastatin on Lipid Profile and CRP Level in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Study
    Darban, Mahboubeh
    Yusefabadi, Elham
    MirmohammadKhani, Majid
    Sohrabi, Bahram
    Bagheri, Bahador
    PHARMACEUTICAL SCIENCES, 2021, 27 (04) : 568 - 574
  • [35] Efficacy and safety of atorvastatin and rosuvastatin in ischemic heart disease patients: A prospective study
    Maqsood, Mariam
    Sadeeqa, Saleha
    Ahmad, Maqsood
    Afzal, Hafsa
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (07) : 1533 - 1538
  • [36] Characteristics of coronary patients with a family history of atherosclerotic disease
    Saely, C
    Aczel, S
    Langer, P
    Marte, T
    Drexel, H
    EUROPEAN HEART JOURNAL, 2002, 23 : 416 - 416
  • [37] The obstructive sleep apnea is not associated with increased atherosclerotic burden in patients with coronary disease: a preliminary study
    Furlan, S.
    Uchoa, C.
    Peres, M.
    Freitas, L.
    Mangione, F.
    Lemos, P.
    Lorenzi-Filho, G.
    Drager, L.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 360 - 361
  • [38] Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease
    Kurtul, Alparslan
    Elcik, Deniz
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 61 - 64
  • [39] Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
    Ndrepepa, G.
    Tada, T.
    Fusaro, M.
    King, L.
    Hadamitzky, M.
    Haase, H. U.
    Schomig, A.
    Pache, J.
    Kastrati, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 783 - 783
  • [40] Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease
    Kurtul, A.
    Elcik, D.
    EUROPEAN HEART JOURNAL, 2017, 38 : 187 - 187
12345